PRCT:NSD-Procept Biorobotics Corp (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 66.73

Change

-0.33 (-0.49)%

Market Cap

USD 3.22B

Volume

0.74M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-23 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

N/A

USD 46.05B
ALGN Align Technology Inc

N/A

USD 19.27B
PODD Insulet Corporation

N/A

USD 13.41B
SWAV Shockwave Medical Inc

N/A

USD 12.57B
BRKR Bruker Corporation

N/A

USD 9.79B
MASI Masimo Corporation

N/A

USD 6.66B
TMDX TransMedics Group Inc

N/A

USD 4.52B
AXNX Axonics Modulation Technologie..

N/A

USD 3.43B
TNDM Tandem Diabetes Care Inc

N/A

USD 3.20B
IRTC iRhythm Technologies Inc

N/A

USD 3.02B

ETFs Containing PRCT

XHE SPDR® S&P Health Care Eq.. 2.24 % 0.35 %

N/A

USD 0.26B
W311:F HAN-GINS Indxx Healthcare.. 1.66 % 0.00 %

N/A

USD 0.02B
WELL:PA HAN-GINS Indxx Healthcare.. 1.66 % 0.00 %

N/A

N/A
WELL:SW HAN-GINS Indxx Healthcare.. 1.66 % 0.00 %

N/A

N/A
WELP:LSE HAN-GINS Indxx Healthcare.. 1.57 % 0.00 %

N/A

USD 0.02B
FFTY Innovator IBD® 50 ETF 0.00 % 0.80 %

N/A

USD 0.09B
FYC First Trust Small Cap Gro.. 0.00 % 0.70 %

N/A

USD 0.27B
FYX First Trust Small Cap Cor.. 0.00 % 0.63 %

N/A

USD 0.85B
WELL:LSE Hanetf Icav - Han-Gins He.. 0.00 % 0.00 %

N/A

USD 0.02B
W311:XETRA HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

N/A

USD 0.02B
DTEC ALPS Disruptive Technolog.. 0.00 % 0.00 %

N/A

USD 0.10B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 59.22% 89% A- 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 59.22% 89% A- 92% A
Trailing 12 Months  
Capital Gain 107.95% 95% A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 107.95% 95% A 95% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.40% 61% D- 69% C-
Dividend Return 10.40% 61% D- 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 32.34% 87% B+ 57% F
Risk Adjusted Return 32.16% 84% B 66% D+
Market Capitalization 3.22B 92% A 85% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector